Form 4 for BEAM Beam Therapeutics Inc.
Accepted 2024-02-15 00:00:00 ET · period of report 2024-02-13 · accession 0001209191-24-003394 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| MI | 2024-02-15 | 2024-02-13+ | BEAM | FMR LLC | See Remark 1 | S - Sale | $30.55 | -901.6K | 2.77M | -25% | -$27.55M |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2024-02-14 | S | D | 45,677 | $31.34 | 1,235,511 | I F-Prime Capital Partners Healthcare Fund V LP | — | — | (F2) The price reported for this transaction is the weighted average price of multiple trades at prices ranging from $31.25 to $31.58. FMR LLC hereby undertakes to provide upon request by the Commission staff, the issuer, or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. |
| 2 | Common | Common Stock | 2024-02-14 | S | D | 854,323 | $30.51 | 1,281,188 | I F-Prime Capital Partners Healthcare Fund V LP | — | — | (F1) The price reported for this transaction is the weighted average price of multiple trades at prices ranging from $30.25 to $31.25. FMR LLC hereby undertakes to provide upon request by the Commission staff, the issuer, or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. |
| 3 | Common | Common Stock | 2024-02-13 | S | D | 410 | $30.28 | 2,773,068 | I Shares held by persons and entities whose shares are subject to reporting by the undersigned | — | — | |
| 4 | Common | Common Stock | 2024-02-13 | S | D | 1,155 | $30.93 | 2,771,913 | I Shares held by persons and entities whose shares are subject to reporting by the undersigned | — | — |